Securities Investigation: ReShape Lifesciences Inc.
Are you concerned about your investment in ReShape Lifesciences Inc. (RSLS)? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Arbitration claim against the brokerage firm that sold you the investment.
ReShape Lifesciences Inc. is a Regulation D private placement investment. Investments such as these are typically sold by brokerage firms in exchange for a large up-front commission. High fees can range from 7-10%, as well as additional “due diligence fees” that can range from 1-3%.
According to filings with the SEC, ReShape Lifesciences Inc. filed a Form D to raise capital from investors in 2018. The total offering amount sold to investors was purportedly $2,793,520.
Private placements investments are a means for smaller companies to raise capital through the sale of equity or debt securities without having to register their securities with the SEC. These investments are often riskier and more complicated than traditional investments, and are only suitable for high net worth, sophisticated investors.
Is a Private Placement Investment Suitable for you?
The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly selling high-risk private placements, like ReShape Lifesciences Inc., to their clients.
Despite the risks of investing in private placements, brokerage firms continue to push this type of investment because of the high commissions associated with their sale and creation. To learn more, see: Regulation D Private Placement Fraud Attorneys
Prior to making recommendations to an individual investor, brokerage firms are required by the Financial Industry Regulatory Authority (FINRA) to disclose all the risks of an investment. Recommendations should only be made if the investment is suitable for an individual investor given their age, investment objections, investment experience and risk tolerance.
Brokerage firms that do not perform adequate due diligence on an investment and/or make unsuitable recommendations can be held accountable for investment losses through FINRA arbitration.
Potential Claims to Recover Investment Losses
If you are concerned about your investment in ReShape Lifesciences Inc., the White Law Group may be able to help you. Please call the offices at 888-637-5510 for a free consultation with a securities attorney.
The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Seattle, Washington. To learn more about the firm’s recent claims involving alternative investments, please see: Centaurus Financial Inc. Lawsuit filed involving High-Risk Alternative Investments
For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://whitesecuritieslaw.com.
Tags: ReShape Lifesciences Inc. complaints, ReShape Lifesciences Inc. investigation, ReShape Lifesciences Inc. investment losses, ReShape Lifesciences Inc. investors, ReShape Lifesciences Inc. losses, ReShape Lifesciences Inc. ppm, ReShape Lifesciences Inc. private placement, ReShape Lifesciences Inc. prospectus, ReShape Lifesciences Inc. recovery options, ReShape Lifesciences Inc. risk, ReShape Lifesciences Inc. stock information, ReShape Lifesciences Inc. update, RSLS Last modified: October 26, 2022